Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Progyny, Inc. (PGNY : NSDQ)

• Company Description    Progyny Inc. is a fertility benefits management company. It specializes in fertility and family building benefits solutions. Progyny Inc. is based in New York, United States. Number of Employees: 680

• Price / Volume Information    Yesterday's Closing Price: $25.68 Daily Weekly Monthly 20 Day Moving Average: 1,241,662 shares Shares Outstanding: 86.21 (millions) Market Capitalization: $2,213.92 (millions) Beta: 0.93 52 Week High: $27.76 52 Week Low: $17.01 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 6.34% 6.52% 12 Week 24.84% 22.83% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1359 BROADWAY - NEW YORK,NY 10018 USA ph: 212-888-3124 fax: - investors@progyny.com http://www.progyny.com

• General Corporate Information    Officers Peter Anevski - Chief Executive Officer and Director David Schlanger - Chairman Mark Livingston - Chief Financial Officer Debra Morris - Director Lloyd Dean - Director Peer Information Progyny, Inc. (CHCR) Progyny, Inc. (ESRX) Progyny, Inc. (MYDP) Progyny, Inc. (COR) Progyny, Inc. (GBCS) Progyny, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 74340E103 SIC: 8090 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/26/26 Share - Related Items Shares Outstanding: 86.21 Most Recent Split Date: (:1) Beta: 0.93 Market Capitalization: $2,213.92 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.24 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.95 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: 16.64% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/26/26

• Fundamental Ratios P/E Current FY Estimate: 27.03 Trailing 12 Months: 43.53 PEG Ratio: 1.62 Price Ratios Price/Book: 3.94 Price/Cash Flow: 74.41 Price / Sales: 1.75 EPS Growth vs. Year Ago Period: 36.36% vs. Previous Quarter: -21.05% Sales Growth vs. Year Ago Period: 9.32% vs. Previous Quarter: -5.87% ROE 12/31/25 - - 09/30/25 - 10.71 06/30/25 - 10.69 ROA 12/31/25 - - 09/30/25 - 7.27 06/30/25 - 7.12 Current Ratio 12/31/25 - - 09/30/25 - 2.95 06/30/25 - 2.70 Quick Ratio 12/31/25 - - 09/30/25 - 2.96 06/30/25 - 2.70 Operating Margin 12/31/25 - - 09/30/25 - 4.14 06/30/25 - 3.96 Net Margin 12/31/25 - - 09/30/25 - 4.46 06/30/25 - 4.28 Pre-Tax Margin 12/31/25 - - 09/30/25 - 7.51 06/30/25 - 7.18 Book Value 12/31/25 - - 09/30/25 - 6.51 06/30/25 - 6.01 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00 Debt-to-Capital 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00

Powered by Zacks Investment Research ©